Isavuconazole
Showing 1 - 25 of 56
Invasive Fungal Disease Trial (Isavuconazole)
Not yet recruiting
- Invasive Fungal Disease
- Isavuconazole
- (no location specified)
Nov 18, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive Trial in Orange, Sacramento, San Diego (Isavuconazonium
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- Aspergillosis Invasive
- Isavuconazonium Injection [Cresemba]
- Placebo
-
Orange, California
- +2 more
Jul 26, 2022
Hematologic Malignancy, Myeloproliferative Disorder Trial in New York (Isavuconazole)
Completed
- Hematologic Malignancy
- Myeloproliferative Disorder
- Isavuconazole
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 15, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Neutropenia Trial in Houston (Isavuconazole)
Completed
- Acute Myeloid Leukemia
- +2 more
- Isavuconazole
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2021
Cerebral Aspergillosis Treated With Isavuconazole
Recruiting
- Cerebral Aspergillosis
- Invasive Aspergillosis
-
Paris, FranceHôpital Necker-Enfants Malades
Sep 6, 2021
Patterns of Real-World Isavuconazole Use -Study of Mucormycosis
Recruiting
- Invasive Aspergillosis
- Mucormycosis
- Isavuconazole
-
Barcelona, SpainFundació Clínic Per A La Recerca Biomèdica
Jun 14, 2021
CNS Lymphoma Trial in Chapel Hill, Winston-Salem (Acalabrutinib, Isavuconazole)
Recruiting
- Central Nervous System Lymphoma
- Acalabrutinib
- Isavuconazole
-
Chapel Hill, North Carolina
- +1 more
Mar 24, 2022
CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)
Recruiting
- Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
- TEDD-R
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Anti-infective Drugs Used in Pediatric Units.
Active, not recruiting
- Population Modeling of Anti-infective Drugs
- Patients requiring cefotaxime treatment
- +4 more
-
Poznań, Długa 1/2, Poland
- +3 more
Jun 21, 2022
Healthy Subjects Trial in Baltimore (Isavuconazonium sulfate IV, Isavuconazonium sulfate capsules)
Completed
- Healthy Subjects
- Isavuconazonium sulfate IV
- Isavuconazonium sulfate capsules
-
Baltimore, MarylandParexel International
Dec 22, 2020
Invasive Mucormycosis, Invasive Aspergillosis Trial in Worldwide (Isavuconazonium sulfate)
Completed
- Invasive Mucormycosis
- Invasive Aspergillosis
- Isavuconazonium sulfate
-
Los Angeles, California
- +9 more
Jan 13, 2023
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
Recruiting
- Aspergillosis
- Mucormycosis
- Isauvuconazole group
-
Seoul, Korea, Republic ofPfizer Korea
Oct 18, 2021
Venetoclax Plasma Concentration and Remission in Acute Myeloid
Not yet recruiting
- Adult Acute Myeloid Leukemia
- Blood sampling for venetoclax drug dosage (venous puncture)
- (no location specified)
Sep 13, 2023
Acute Respiratory Failure, Immunocompromised Patients Trial (Experimental for steroid, Experimental for antifungals,
Not yet recruiting
- Acute Respiratory Failure
- Immunocompromised Patients
- Experimental for steroid
- +3 more
- (no location specified)
Dec 18, 2020
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023
Hematological Malignancy Trial in United States (isavuconazonium sulfate - intravenous, isavuconazonium sulfate - oral)
Completed
- Hematological Malignancy
- isavuconazonium sulfate - intravenous
- isavuconazonium sulfate - oral
-
Long Beach, California
- +15 more
Jun 30, 2020
Mucormycosis; Pulmonary (Etiology) Trial in Chandigarh (Posaconazole 600 mg followed by posaconazole 300 mg once daily,
Recruiting
- Mucormycosis; Pulmonary (Etiology)
- Posaconazole 600 mg followed by posaconazole 300 mg once daily
- Liposomal Amphotericin B
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Jul 19, 2022
Febrile Neutropenia Trial (Early Discontinuation of Antibiotics, Standard of Care)
Not yet recruiting
- Febrile Neutropenia
- Early Discontinuation of Antibiotics
- Standard of Care
- (no location specified)
Mar 24, 2023
Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)
Recruiting
- Previously Untreated Acute Myeloid Leukemia
- Samalizumab (BAML-16-001-S1)
- +32 more
-
Phoenix, Arizona
- +18 more
Oct 17, 2022
CNS Infections, CNS Complication, Infectious Disease of Nervous System Trial in Worldwide
Recruiting
- Central Nervous System Infections
- +5 more
-
Westmead, Australia
- +16 more
Jun 1, 2022
Bacterial Infections, Fungal Infection Trial in Spain (Non-impositive Program for Optimizing the Use of Antimicrobials)
Unknown status
- Bacterial Infections
- Fungal Infection
- Non-impositive Program for Optimizing the Use of Antimicrobials
-
Almería, Spain
- +13 more
May 28, 2020
Aspergillosis, Invasive Fungal Infection Trial in Worldwide (Isavuconazole, Voriconazole)
Completed
- Aspergillosis
- Invasive Fungal Infection
- Isavuconazole
- Voriconazole
-
Birmingham, Alabama
- +106 more
Mar 25, 2019